David Happel - Insider Trading & Ownership

Location
7 Hamilton Landing, Suite 100, Novato, CA
Summary
The estimated net worth of David Happel is at least $2.19M dollars as of July 23, 2025. David Happel is the President & CEO, Director of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $2.19M.
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of David Happel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGMT Sagimet Biosciences Inc. President & CEO, Director $2.19M Jul 21, 2025

Insider Transactions Reported by David Happel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.